Energy costs drive up price of packaging
Soaring energy costs are driving up the price of packaging materials. Anthony Fletcher looks at the state of the market for polyethylene, polypropylene and polystyrene.
Soaring energy costs are driving up the price of packaging materials. Anthony Fletcher looks at the state of the market for polyethylene, polypropylene and polystyrene.
A new method to improve the accuracy and speed of protein visualization has been developed. The technique, which uses a novel set of biosensor dyes, promises to dramatically increase the accuracy and speed of the technique, used in the pharmaceutical...
A whole new generation of drug treatments and therapies for stroke, migraine, Alzheimer's and other brain disorders could be created after the discovery of a mechanism for regulating brain blood flow was made by researchers.
The chief executive of Akzo Nobel expects to record sales of more than $1 billion in China within the next five years, more than double the level at present, and is boosting its presence in the country in anticipation.
US chemical company Aceto has reported a healthy rise in sales and operating income in the year ended 30 June, helped by its recent entry into the market for biopharmaceuticals.
DSM Nutritional Products has lifted its vitamin E capacity to 25,000 tons - the world's largest - at a new plant that is being hailed for its production efficiencies, reports Dominique Patton.
Biotechnology Company, Nucleonics, has filed a request with the Commissioner of Patents in Australia for Re-Examination, which questions the validity of Benitec's patent concerning gene-silencing technology claiming ambiguity and lack adequate...
Needle free injector specialist Bioject Medical Technologies has won a new contract to supply its drug vial adaptor product, designed to make syringe filling completely needle free.
Bayer has continued the sweeping reforms across its business with the creation of a broad pharmaceuticals alliance with US drugmaker Schering-Plough.
US life science company Serologicals has entered into a €167.6 million merger with cell signallin specialist Upstate, creating a significant presence in the preclinical drug screening and target validation market, the fastest growing segment of the...
Proliant Biologicals has launched a new cell culture medium that can be used for the production of monoclonal antibodies and other proteins but is claimed to be more economical than a rival product.